
Avantor (AVTR) Stock
Global life sciences consumables and distribution leader. Here's the price, business snapshot, and what's worth knowing about Avantor in November 2026.
Avantor Inc (NYSE: AVTR) is a global supplier of products, services and consumables to the life sciences, healthcare and advanced technologies markets. The company offers laboratory chemicals, ultrapurified water solutions, bioprocessing supplies and distribution services used by pharmaceutical, biotech, academic and industrial customers. With a market capitalisation of around $10.64 billion, Avantor’s business is driven by recurring demand for lab consumables, growth in biologics and diagnostics, and expansion into international markets. Investors often watch revenue diversity across healthcare and industrial end-markets, margins on speciality products, and cash generation. Key risks include exposure to raw-material and logistics costs, customer concentration, regulatory changes and competitive pressure. Avantor may pursue acquisitions to bolster its portfolio, which can affect leverage and integration risk. This summary is for educational purposes only and not personalised investment advice; values can rise and fall and past performance does not guarantee future returns. Consider suitability and seek independent advice if unsure.
Six-Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Avantor's stock with a target price of $21.93, indicating modest growth potential.
Financial Health
Avantor Inc is performing well with strong revenue and cash flow, indicating healthy business operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Steady Consumables Demand
Recurring purchases of lab reagents and disposables can provide reliable revenue, though end-market cycles and budget shifts may affect volumes.
Global Footprint
Broad geographic reach helps diversify customers across pharma, academia and industry, but exposes the business to currency and regional regulatory risks.
Operational Levers
Efficiency, pricing on speciality products and integration of acquisitions can lift margins, though execution and cost pressures are ongoing considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.